Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Rozeman, E.A.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(25)
+
-
Availability
Open access
(23)
+
-
Metadata Only
(2)
+
-
Creation Date
2018
(5)
+
-
2017
(4)
+
-
2020
(4)
+
-
2021
(4)
+
-
2022
(4)
+
-
2019
(3)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(11)
+
-
Collection
Scholarly Publications
(14)
+
-
Medicine / Leiden University Medical Centre (LUMC)
(11)
+
-
Topic
immunotherapy
(4)
+
-
melanoma
(3)
+
-
Melanoma
(2)
+
-
checkpoint inhibition
(2)
+
-
immune checkpoint inhibition
(2)
+
-
Author
Rozeman, E.A.
(25)
+
-
Blank, C.U.
(22)
+
-
Haanen, J.B.A.G.
(13)
+
-
Wiel, B.A. van de
(10)
+
-
Long, G.V.
(9)
+
-
Scolyer, R.A.
(9)
+
-
Akkooi, A.C.J. van
(8)
+
-
Ch'ng, S.
(8)
+
-
Menzies, A.M.
(8)
+
-
Saw, R.P.M.
(8)
+
-
Reijers, I.L.M.
(7)
+
-
Sikorska, K.
(7)
+
-
Thienen, J.V. van
(7)
+
-
Versluis, J.M.
(7)
+
-
Houdt, W.J. van
(6)
+
-
Klop, W.M.C.
(6)
+
-
Wouters, M.W.
(6)
+
-
Gonzalez, M.
(5)
+
-
Grijpink-Ongering, L.G.
(5)
+
-
Kapiteijn, E.
(5)
+
-
Spillane, A.J.
(5)
+
-
Zuur, C.L.
(5)
+
-
Acosta, A.T.
(4)
+
-
Broeks, A.
(4)
+
-
Krijgsman, O.
(4)
+
-
Peeper, D.S.
(4)
+
-
Rawson, R.V.
(4)
+
-
Shannon, K.F.
(4)
+
-
Bierman, C.
(3)
+
-
Boekhout, A.H.
(3)
+
-
Colebatch, A.J.
(3)
+
-
Eriksson, H.
(3)
+
-
Hoefsmit, E.P.
(3)
+
-
Jozwiak, K.
(3)
+
-
Lalezari, F.
(3)
+
-
Nieweg, O.E.
(3)
+
-
Poll-franse, L.V. van de
(3)
+
-
Suijkerbuijk, K.P.M.
(3)
+
-
Warren, S.
(3)
+
-
Adriaansz, S.
(2)
+
-
Dimitriadis, P.
(2)
+
-
Foppen, M.H.G.
(2)
+
-
Grunhagen, D.J.
(2)
+
-
Haanen, J.B.
(2)
+
-
Hage, J.A. van der
(2)
+
-
Heuvel, N.M.J. van den
(2)
+
-
Hospers, G.A.P.
(2)
+
-
Kemper, K.
(2)
+
-
Kerkhoven, R.M.
(2)
+
-
Kuilman, T.
(2)
+
-
Lijnsvelt, J.M.
(2)
+
-
Mallo, H.
(2)
+
-
Mallo, H.A.
(2)
+
-
Meier, M.A.J.
(2)
+
-
Pennington, T.E.
(2)
+
-
Prevoo, W.
(2)
+
-
Schilling, B.
(2)
+
-
Schumacher, T.N.
(2)
+
-
Schumacher, T.N.M.
(2)
+
-
Shahrabi, A.
(2)
+
-
Song, J.Y.
(2)
+
-
T.M. van
(2)
+
-
Tetzlaff, M.T.
(2)
+
-
Tinteren, H. van
(2)
+
-
Veldt, A.A.M. van der
(2)
+
-
Wal, J.E. van der
(2)
+
-
Wilgenhof, S.
(2)
+
-
Witkamp, A.J.
(2)
+
-
Show more
Language
en
(25)
+
-
Search results
(1 - 24 of 25)
Pages
1
2
›
››
show grid
show list
save search
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial
Diagnostic performance of early increase in S100B or LDH as outcome predictor for non-responsiveness to anti-PD-1 monotherapy in advanced melanoma
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
Original Research Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
Health-related quality of life of long-term advanced melanoma survivors treated with anti-CTLA-4 immune checkpoint inhibition compared to matched controls
Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)
B cells and tertiary lymphoid structures promote immunotherapy response
Comprehensive analysis of cutaneous and uveal melanoma liver metastases
Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors
Switch to checkpoint inhibition (CPI) after targeted therapy (TT) at time of progression or during ongoing response: A retrospective analysis of patients with advanced BRAF mutated melanoma
Targeting tumor-associated acidity in cancer immunotherapy
Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors
Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
Pharmacogenetic variants associated with outcome in patients with advanced gastric cancer treated with fluoropyrimidine and platinum-based triplet combinations: a pooled analysis of three prospective studies
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Combined radiofrequency ablation and ipilimumab in uveal melanoma: Results from the SECIRA-UM trial
Pages
1
2
›
››